Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge

Douglas C. Wolf, Samuel M. Cohen, Alan R. Boobis, Vicki L. Dellarco, Penelope A. Fenner-Crisp, Angelo Moretto, Timothy P. Pastoor, Rita S. Schoeny, Jennifer G. Seed, John E. Doe

Research output: Contribution to journalComment/debate

2 Citations (Scopus)

Abstract

Developments in the understanding of the etiology of cancer have profound implications for the way the carcinogenicity of chemicals is addressed. This paper proposes a unified theory of carcinogenesis that will illuminate better ways to evaluate and regulate chemicals. In the last four decades, we have come to understand that for a cell and a group of cells to begin the process of unrestrained growth that is defined as cancer, there must be changes in DNA that reprogram the cell from normal to abnormal. Cancer is the consequence of DNA coding errors that arise either directly from mutagenic events or indirectly from cell proliferation especially if sustained. Chemicals that act via direct interaction with DNA can induce cancer because they cause mutations which can be carried forward in dividing cells. Chemicals that act via non-genotoxic mechanisms must be dosed to maintain a proliferative environment so that the steps toward neoplasia have time to occur. Chemicals that induce increased cellular proliferation can be divided into two categories: those which act by a cellular receptor to induce cellular proliferation, and those which act via non-specific mechanisms such as cytotoxicity. This knowledge has implications for testing chemicals for carcinogenic potential and risk management.

Original languageEnglish (US)
Pages (from-to)86-92
Number of pages7
JournalRegulatory Toxicology and Pharmacology
Volume103
DOIs
StatePublished - Apr 2019

Fingerprint

Cell Proliferation
Neoplasms
DNA
Coding errors
Risk Management
Cell proliferation
Cytotoxicity
Risk management
Carcinogenesis
Mutation
Growth
Testing

Keywords

  • Carcinogenicity
  • Mode of action
  • Risk assessment

ASJC Scopus subject areas

  • Toxicology

Cite this

Chemical carcinogenicity revisited 1 : A unified theory of carcinogenicity based on contemporary knowledge. / Wolf, Douglas C.; Cohen, Samuel M.; Boobis, Alan R.; Dellarco, Vicki L.; Fenner-Crisp, Penelope A.; Moretto, Angelo; Pastoor, Timothy P.; Schoeny, Rita S.; Seed, Jennifer G.; Doe, John E.

In: Regulatory Toxicology and Pharmacology, Vol. 103, 04.2019, p. 86-92.

Research output: Contribution to journalComment/debate

Wolf, DC, Cohen, SM, Boobis, AR, Dellarco, VL, Fenner-Crisp, PA, Moretto, A, Pastoor, TP, Schoeny, RS, Seed, JG & Doe, JE 2019, 'Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge', Regulatory Toxicology and Pharmacology, vol. 103, pp. 86-92. https://doi.org/10.1016/j.yrtph.2019.01.021
Wolf, Douglas C. ; Cohen, Samuel M. ; Boobis, Alan R. ; Dellarco, Vicki L. ; Fenner-Crisp, Penelope A. ; Moretto, Angelo ; Pastoor, Timothy P. ; Schoeny, Rita S. ; Seed, Jennifer G. ; Doe, John E. / Chemical carcinogenicity revisited 1 : A unified theory of carcinogenicity based on contemporary knowledge. In: Regulatory Toxicology and Pharmacology. 2019 ; Vol. 103. pp. 86-92.
@article{554fcc424dd04b968be28fd3dc6d3286,
title = "Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge",
abstract = "Developments in the understanding of the etiology of cancer have profound implications for the way the carcinogenicity of chemicals is addressed. This paper proposes a unified theory of carcinogenesis that will illuminate better ways to evaluate and regulate chemicals. In the last four decades, we have come to understand that for a cell and a group of cells to begin the process of unrestrained growth that is defined as cancer, there must be changes in DNA that reprogram the cell from normal to abnormal. Cancer is the consequence of DNA coding errors that arise either directly from mutagenic events or indirectly from cell proliferation especially if sustained. Chemicals that act via direct interaction with DNA can induce cancer because they cause mutations which can be carried forward in dividing cells. Chemicals that act via non-genotoxic mechanisms must be dosed to maintain a proliferative environment so that the steps toward neoplasia have time to occur. Chemicals that induce increased cellular proliferation can be divided into two categories: those which act by a cellular receptor to induce cellular proliferation, and those which act via non-specific mechanisms such as cytotoxicity. This knowledge has implications for testing chemicals for carcinogenic potential and risk management.",
keywords = "Carcinogenicity, Mode of action, Risk assessment",
author = "Wolf, {Douglas C.} and Cohen, {Samuel M.} and Boobis, {Alan R.} and Dellarco, {Vicki L.} and Fenner-Crisp, {Penelope A.} and Angelo Moretto and Pastoor, {Timothy P.} and Schoeny, {Rita S.} and Seed, {Jennifer G.} and Doe, {John E.}",
year = "2019",
month = "4",
doi = "10.1016/j.yrtph.2019.01.021",
language = "English (US)",
volume = "103",
pages = "86--92",
journal = "Regulatory Toxicology and Pharmacology",
issn = "0273-2300",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Chemical carcinogenicity revisited 1

T2 - A unified theory of carcinogenicity based on contemporary knowledge

AU - Wolf, Douglas C.

AU - Cohen, Samuel M.

AU - Boobis, Alan R.

AU - Dellarco, Vicki L.

AU - Fenner-Crisp, Penelope A.

AU - Moretto, Angelo

AU - Pastoor, Timothy P.

AU - Schoeny, Rita S.

AU - Seed, Jennifer G.

AU - Doe, John E.

PY - 2019/4

Y1 - 2019/4

N2 - Developments in the understanding of the etiology of cancer have profound implications for the way the carcinogenicity of chemicals is addressed. This paper proposes a unified theory of carcinogenesis that will illuminate better ways to evaluate and regulate chemicals. In the last four decades, we have come to understand that for a cell and a group of cells to begin the process of unrestrained growth that is defined as cancer, there must be changes in DNA that reprogram the cell from normal to abnormal. Cancer is the consequence of DNA coding errors that arise either directly from mutagenic events or indirectly from cell proliferation especially if sustained. Chemicals that act via direct interaction with DNA can induce cancer because they cause mutations which can be carried forward in dividing cells. Chemicals that act via non-genotoxic mechanisms must be dosed to maintain a proliferative environment so that the steps toward neoplasia have time to occur. Chemicals that induce increased cellular proliferation can be divided into two categories: those which act by a cellular receptor to induce cellular proliferation, and those which act via non-specific mechanisms such as cytotoxicity. This knowledge has implications for testing chemicals for carcinogenic potential and risk management.

AB - Developments in the understanding of the etiology of cancer have profound implications for the way the carcinogenicity of chemicals is addressed. This paper proposes a unified theory of carcinogenesis that will illuminate better ways to evaluate and regulate chemicals. In the last four decades, we have come to understand that for a cell and a group of cells to begin the process of unrestrained growth that is defined as cancer, there must be changes in DNA that reprogram the cell from normal to abnormal. Cancer is the consequence of DNA coding errors that arise either directly from mutagenic events or indirectly from cell proliferation especially if sustained. Chemicals that act via direct interaction with DNA can induce cancer because they cause mutations which can be carried forward in dividing cells. Chemicals that act via non-genotoxic mechanisms must be dosed to maintain a proliferative environment so that the steps toward neoplasia have time to occur. Chemicals that induce increased cellular proliferation can be divided into two categories: those which act by a cellular receptor to induce cellular proliferation, and those which act via non-specific mechanisms such as cytotoxicity. This knowledge has implications for testing chemicals for carcinogenic potential and risk management.

KW - Carcinogenicity

KW - Mode of action

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=85060300162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060300162&partnerID=8YFLogxK

U2 - 10.1016/j.yrtph.2019.01.021

DO - 10.1016/j.yrtph.2019.01.021

M3 - Comment/debate

C2 - 30634023

AN - SCOPUS:85060300162

VL - 103

SP - 86

EP - 92

JO - Regulatory Toxicology and Pharmacology

JF - Regulatory Toxicology and Pharmacology

SN - 0273-2300

ER -